CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
Lundin J, Osterborg A, Brittinger G, Crowther D, Dombret H, Engert A, Epenetos A, Gisselbrecht C, Huhn D, Jaeger U, Thomas J, Marcus R, Nissen N, Poynton C, Rankin E, Stahel R, Uppenkamp M, Willemze R, Mellstedt H.
Lundin J, et al. Among authors: huhn d.
J Clin Oncol. 1998 Oct;16(10):3257-63. doi: 10.1200/JCO.1998.16.10.3257.
J Clin Oncol. 1998.
PMID: 9779699
Clinical Trial.